IF by specialty › Oncology
Critical Reviews in Oncology/Hematology — Impact Factor
The 2025 Impact Factor of Critical Reviews in Oncology/Hematology is 6.2 (Q1 in Hematology; subscription or hybrid).
- Impact Factor
- 6.2 JCR 2025
- JCR category
- Oncology, Hematology
- Quartile
- Q1 in Hematology
- Publisher
- Elsevier
- Open access
- subscription or hybrid
- IF source
- bioxbio.com
Position within the field
Ranked 22 of the 42 journals in Oncology on this site (bottom 50%).
Oncology journals with a similar Impact Factor
- International Journal of Radiation Oncology, Biology, Physics IF 7.4
- Gastric Cancer IF 6.1
- Radiotherapy and Oncology IF 5.8
- Cancer IF 5.6
- JCO Oncology Practice IF 5.5
- Lung Cancer IF 5.3
About this value
The Journal Impact Factor of Critical Reviews in Oncology/Hematology (JCR 2025, released June 2026) is 6.2. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.